Satsuma Pharmaceuticals, Inc. acquired Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc. -> Satsuma Pharmaceuticals, Inc. · $0.0001

As previously disclosed, on November 3, 2022, the Company entered into an At-the-Market Sales Agreement (the “Sales Agreement”) with Virtu Americas LLC (“Virtu”) with respect to an “at-the-market” offering program under which the Company could offer and sell,